Immunological tolerance induced by in utero injection

Area of Science:

• Immunology
• Developmental Biology
• Transplantation Medicine

Background:

• Establishing immune tolerance is crucial for preventing transplant rejection and autoimmune diseases.
• Fetal immune system development offers a unique window for inducing tolerance.
• Previous methods for inducing tolerance have limitations.

Purpose of the Study:

• To investigate the feasibility of inducing immune tolerance via intrauterine fetal injection.
• To assess the safety and efficacy of allogeneic bone marrow cell transplantation in fetal rabbits.
• To explore the potential of this approach for correcting inherited diseases.

Main Methods:

• Intrauterine injection of human whole blood into fetal rabbits and rhesus monkeys.
• Intrauterine injection of viable allogeneic bone marrow cells into fetal rabbits.
• Monitoring for immune unresponsiveness to human serum albumin.
• Donor red cell survival studies to assess engraftment and tolerance.

Main Results:

• Intrauterine injection of human whole blood induced long-lasting unresponsiveness to human serum albumin.
• Intrauterine injection of allogeneic bone marrow cells had no apparent harmful effects.
• Bone marrow cell injections resulted in permanent immune unresponsiveness, confirmed by donor red cell survival.

Conclusions:

• Intrauterine allogeneic bone marrow cell transplantation is a safe and effective method for inducing long-term immune tolerance in fetal rabbits.
• This approach holds promise for the prenatal correction of certain inherited diseases in humans.
• Further research is warranted to translate these findings to clinical applications.